CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Cash Flows From Operating Activities:
Net loss	$ (2,193,358)	$ (1,417)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	$ 380,680	368,447
Stock compensation expense		392,871
Common stock issued for services rendered	$ 133,000	$ 286,780
Write-off of abandoned patents	$ 320,160
Gain on disposal of property and equipment		$ (188,869)
Common stock issued for interest on convertible debentures & preferred stock	$ 156,600	689,850
Change in fair value of derivative liabilities	(1,488,237)	(4,525,739)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	(117,739)	(490,352)
Deferred revenue	(223,662)	(1,181)
Other current assets	147,820	(104,015)
Net Cash Used in Operating Activities	$ (2,884,736)	$ (3,573,625)
Cash Flows From Investing Activities:
Purchase of property and equipment
Proceeds from sale of property and equipment		$ 883,780
Costs incurred for patents	$ (90,982)	(89,481)
Net Cash (Used In)/Provided By Investing Activities	$ (90,982)	794,299
Cash Flows From Financing Activities:
Repayment of long-term debt		(606,806)
Proceeds from exercise of warrants, net		2,301,944
Proceeds from exercise of stock options	$ 6,416	526
Proceeds from issuance of preferred stock, net	475,000	2,655,000
Net Cash Provided by Financing Activities	481,416	4,350,664
Effect of Exchange Rates on Cash	(25,222)	(10,803)
Net (Decrease)/Increase in Cash and Cash Equivalents	(2,519,524)	1,560,535
Cash and Cash Equivalents, Beginning of Year	3,269,489	1,708,954
Cash and Cash Equivalents, End of Year	$ 749,965	3,269,489
Supplemental Disclosure of Cash Flow Information
Interest paid in cash		$ 35,541